CHARACTERIZATION OF THE CORONARY VASCULAR-RESPONSES TO PLATELET-ACTIVATING-FACTOR IN THE ISOLATED PERFUSED HEART

被引:8
作者
HU, WM
CHOY, PC
MAN, RYK
机构
[1] UNIV MANITOBA,FAC MED,DEPT PHARMACOL & THERAPEUT,770 BANNATYNE AVE,WINNIPEG R3E 0W3,MANITOBA,CANADA
[2] UNIV MANITOBA,FAC MED,DEPT BIOCHEM,WINNIPEG R3E 0W3,MANITOBA,CANADA
关键词
D O I
10.1007/BF02535617
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Platelet-activating factor (PAF) is a potent phospholipid mediator with diverse in vivo and in vitro coronary vascular effects. In the present study, the coronary vascular responses to bolus injections of PAF were compared in rat hearts perfused under constant flow and under constant pressure. Low levels of PAF (1 pmol) produced vasodilatation only, while higher PAF concentrations (100 pmol) produced initial vasodilatation which was followed by a vasoconstriction under both experimental conditions. To determine species differences in PAF action, the effect of PAF was tested on perfused guinea pig hearts. Unlike in perfused rat hearts, only a dose-dependent vasoconstrictor response was observed in perfused guinea pig hearts following a bolus injection of 1 fmol to 10 pmol of PAF. The results from repeated injections of PAF indicated that depletion of vasoactive mediators induced by PAF or receptor densensitization may explain a failure of a second injection of PAF to initiate a vasoconstrictor response. After PAF injection, the coronary vascular response to leukotriene was not altered, indicating that the reduced vasoconstrictor effect of a second injection of PAF cannot be due to a reduced ability of the smooth muscle to constrict. The study demonstrates that similar coronary vascular responses to PAF are observed in perfused rat hearts under either constant flow rate or constant pressure and that some of the variable coronary vascular responses reported may be due to the difference between animal species.
引用
收藏
页码:700 / 704
页数:5
相关论文
共 17 条
  • [1] BRAQUET P, 1987, PHARMACOL REV, V39, P97
  • [2] CARGILL DI, 1983, THROMB HAEMOSTASIS, V49, P204
  • [3] DEMOPOULOS CA, 1979, J BIOL CHEM, V254, P9355
  • [4] CARDIAC AND CORONARY CONSEQUENCES OF INTRACORONARY PLATELET-ACTIVATING-FACTOR INFUSION IN THE DOMESTIC PIG
    EZRA, D
    LAURINDO, FRM
    CZAJA, JF
    SNYDER, F
    GOLDSTEIN, RE
    FEUERSTEIN, G
    [J]. PROSTAGLANDINS, 1987, 34 (01): : 41 - 57
  • [5] EFFECT OF PLATELET-ACTIVATING FACTOR ON CORONARY CIRCULATION OF THE DOMESTIC PIG
    FEUERSTEIN, G
    BOYD, LM
    EZRA, D
    GOLDSTEIN, RE
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1984, 246 (03): : H466 - H471
  • [6] COMPARISON OF CARDIAC AND HEMODYNAMIC-EFFECTS OF PLATELET-ACTIVATING FACTOR-ACETHER AND LEUKOTRIENE D4 IN ANESTHETIZED DOGS
    FIEDLER, VB
    MARDIN, M
    ABRAM, TS
    [J]. BASIC RESEARCH IN CARDIOLOGY, 1987, 82 (02) : 197 - 208
  • [7] PLATELET-ACTIVATING-FACTOR - A BIOLOGICALLY-ACTIVE PHOSPHOGLYCERIDE
    HANAHAN, DJ
    [J]. ANNUAL REVIEW OF BIOCHEMISTRY, 1986, 55 : 483 - 509
  • [8] PLATELET-ACTIVATING-FACTOR AND THE RELEASE OF A PLATELET-DERIVED CORONARY-ARTERY VASODILATOR SUBSTANCE IN THE CANINE
    JACKSON, CV
    SCHUMACHER, WA
    KUNKEL, SL
    DRISCOLL, EM
    LUCCHESI, BR
    [J]. CIRCULATION RESEARCH, 1986, 58 (02) : 218 - 229
  • [9] LEFER A M, 1985, P59
  • [10] LETTS LG, 1983, ADV PROSTAG THROMB L, V11, P391